Posts tagged ‘IBM’

December 26, 2013

IBM reveals its top five innovation predictions for the next five years: ‘Everything will learn’

IBM revealed its predictions for five big innovations that will change our lives within five years.

The IBM 5 in 5 is the eighth year in a row that IBM has made predictions about technology, and this year’s prognostications are sure to get people talking. We discussed them with Bernie Meyerson, vice president of innovation at IBM, and he told us that the goal of the predictions is to better marshal the company’s resources in order to make them come true.

“We try to get a sense of where the world is going because that focuses where we put our efforts,” Meyerson said. “The harder part is nailing down what you want to focus on. Unless you stick your neck out and say this is where the world is going, it’s hard to you can turn around and say you will get there first. These are seminal shifts. We want to be there, enabling them.”

In a nutshell, IBM says:

– The classroom will teach you.
– Buying local will beat online.
– Doctors will use your DNA to keep you well.
– A digital guardian will protect you online.
– The city will help you live in it.

Meyerson said that this year’s idea

See on medcitynews.com

See on Scoop.it – Pharmaceutical Industry digital vision

Advertisements
Tags:
November 4, 2013

The David And Goliath Of Health Care: Apple’s Siri Vs. IBM’s Watson

In every strength lies a weakness and in every weakness a strength. This maxim has held true throughout history – from biblical days to the battles of modern times.

And it holds just as true in the information technology (IT) “arms race” that’s playing out in American health care today.

In Malcolm Gladwell’s newest work “David and Goliath,” he suggests that when we fail to recognize both the strengths and weaknesses of different alternatives, we risk not seeing the best solutions. Gladwell argues that we tend to overvalue one particular trait, such as Goliath’s size, while failing to recognize a seemingly less powerful skill, like David’s slingshot ability. The important thing is that each holds a tactical advantage, depending on the conditions of battle.

There is much discussion about how technology can solve the health care problems our nation faces. One proposed  solution is application of “big data,” (sets of data that are too varying and complex to process with commonly used software tools). Another high-tech solution comes by way of the algorithmic care that’s already available in mobile technology. Think of these two solutions as Watson and Siri. Big and strong vs. small and nimble. David and Goliath.

See on www.forbes.com

From Pharmaceutical Industry digital vision

November 3, 2013

Comment IBM invente une e-santé made in France

A quelques kilomètres de Nice, le centre de solutions métiers d’IBM de La Gaude a développé une expertise mondiale en santé.

C’est ici que le géant informatique fait la démonstration des technologiques, qu’il proposera ensuite à ses clients à travers le monde.

Depuis 1961, il surplombe la ville de Nice. Lorsqu’IBM a fondé un centre à la Gaude, c’était pour servir les divisions produits, réseaux et télécoms, et réaliser des protocoles réseaux à l’heure où Internet n’existait pas encore. C’est entre cet établissement et une usine américaine qu’a été réalisée la première liaison transatlantique entre deux ordinateurs ! Depuis, La Gaude a pris de l’ampleur. Devenant un centre de solutions où travaille une centaine d’employés pour une dizaine de métiers : banque, villes intelligentes, énergie, santé… “Il s’agit d’un des deux centres mondiaux d’IBM – avec le site de Dallas – où le point d’entrée pour les clients passe par les métiers et leur transformation”, raconte François Commagnac, responsable du secteur santé à La Gaude. Objectif du site, faire la démonstration des technologies et services qu’IBM peut proposer à ses clients pour valoriser et sécuriser leurs données, en utilisant les meilleurs cas d’usage puisés à travers le monde. Il faut donc leur en mettre plein la vue…

See on www.usine-digitale.fr

From Pharmaceutical Industry digital vision

Tags:
October 28, 2013

BIG DATA : ET SI LA MONTAGNE ACCOUCHAIT D’UNE SOURIS ?

Ce mois d’octobre aura été riche en actualités sur les données de santé et le BIG DATA.

En effet, selon IBM, chaque jour, nous générons 2,5 trillions d’octets de données. A tel point que 90% des données dans le monde ont été créées au cours des deux dernières années seulement. Il en va de même en santé.

Enjeux de tous les fantasmes.. de tous les espoirs …cette question est au cœur des évolutions des systèmes de santé.

D’une part des données publiques qui pourraient permettre de mieux comprendre et gérer les systèmes de soin mais dont l’anonymat et le bon usage doivent être garantis.

D’autre part des données individuelles que de plus en plus d’utilisateurs génèrent à travers des objets connectés, ou simplement leur Smartphone, dans cette nouvelle tendance appelée le « quantifiedself ».

DONNEES PUBLIQUES DE SANTE : 1.2 MILLIARD D’ENREGISTREMENTS PAR AN

C’était le 03 octobre dernier, Marisol Touraine recevait des mains de Pierre Louis BRAS, Inspecteur General des affaires sociales qu’elle avait missionné en avril 2013, son rapport sur la gouvernance et l’utilisation des données de santé.

See on club-digital-sante.fr

From Pharmaceutical Industry digital vision

Tags:
October 28, 2013

IBM’s Watson recommending cancer treatments at MD Anderson – MedCity News

MD Anderson launched a program last year to eradicate eight different forms of cancer, with an initial focus on Leukemia.

Tech companies have a preferred term to describe their most ambitious and meaningful projects: “moonshots.”

Google chief executive Larry Page borrowed it from John F. Kennedy, who 50 years ago challenged Congress and the nation to put a man on the moon. Today, IBM executives used the term to describe how the Watson super computer is fighting cancer, and a new initiative that is a veritable moonshot.

IBM’s stab at bringing information technology to healthcare is more than just a publicity stunt. The technology giant is working closely with the MD Anderson Cancer Center at the University of Texas, which is one of the top cancer research facilities in the country. MD Anderson launched a program last year to eradicate eight different forms of cancer, with an initial focus on Leukemia.

“I’m exceptionally optimistic about what the future holds in the potential treatment and eradication in these forms of cancer,” said Steve Gold, IBM’s vice president of marketing for Watson Solutions, in an interview.

IBM Watson: Not just a jeopardy winner

After all the hype around Watson, a new computing system that crushed humans at Jeopardy, we mostly forgot about it. That’s because IBM’s team of engineers have been heads down, feeding Watson information, so it can understand the language of medicine and not just general knowledge.

See on medcitynews.com

From Pharmaceutical Industry digital vision

Tags:
October 24, 2013

IBM met son savoir-faire au service des hopitaux | L’Atelier: Disruptive innovation

Grâce à l’analyse de données Big Data, chercheurs et développeurs cherchent à prédire l’apparition de maladies chroniques et mieux former les médecins.

Alors que les crises cardiaques constituent la première cause de décès et d’hospitalisation lourde aux Etats-Unis, un cinquième des adultes américains sont susceptibles de développer une insuffisance cardiaque, maladie difficilement détectable préventivement. IBM en s’associant avec plusieurs centres de recherche hospitaliers américains cherche à développer des outils d’analyse Big Data pouvant assister les médecins dans la détection de profils vulnérables. Cette stratégie illustre une tendance de fond dans le domaine de la santé, la constitution d’alliances entre grands groupes pharmaceutiques, centres de recherche et développeurs de logiciels pour exploiter les applications Big Data.

Identifier les facteurs de risque

De nombreux partenariats entre développeurs de logiciels et hôpitaux se multiplient afin d’utiliser la data pour élaborer de nouvelles thérapies contre le cancer grâce à une approche «multi-omique»c’est à dire incluant à la fois les caractères génomiques, protéomiques et métaboliques.  La mutualisation des données permettant de créer des modèles prédictifs repérant les points communs à l’ensemble des profils enregistrés. IBM s’est ainsi associé avec Sutter Health et Geisinger Health Systems pour élaborer un programme de détection précoce de facteurs de crise cardiaque. La société utilise un système innovant d’Unstructured Information Management Architecture (UIMA) analysant à la fois les dossiers des patients et données issues de revues médicales et de précédents cas traités. Face à l’absence d’un unique indicateur pertinent, le système détecte des indicateurs de « co-morbidité » comme l’hypertension ou le diabète ou l’utilisation de médicaments spécifiques.

See on www.atelier.net

From Pharmaceutical Industry digital vision

Tags:
October 24, 2013

IBM Watson fires its own cancer-fighting ‘moonshot’

Cancer research hospital MD Anderson launched a program, in partnership with IBM Watson, to eradicate eight different forms of cancer.

Tech companies have a preferred term to describe their most ambitious and meaningful projects: “moonshots.”

Google chief executive Larry Page borrowed it from John F. Kennedy, who 50 years ago challenged Congress and the nation to put a man on the moon. Today, IBM executives used the term to describe how the Watson super computer is fighting cancer, and a new initiative that is a veritable moonshot.

IBM’s stab at bringing information technology to healthcare is more than just a publicity stunt. The technology giant is working closely with the MD Anderson Cancer Center at the University of Texas, which is one of the top cancer research facilities in the country. MD Anderson launched a program last year to eradicate eight different forms of cancer, with an initial focus on Leukemia.

MD Anderson’s program has enjoyed tremendous financial support in its first year, with more than $139 million in private philanthropic commitments. Oil heiress Lyda Hill has donated $50 million to the program. The funding has gone to support new technologies, like the IBM Watson, and doctors performing new research on eight specific cancer types: melanoma, myeloid and lymphocytic leukemias, myelodysplastic syndromes, and lung, prostate, breast, and ovarian cancers.

See on venturebeat.com

From Pharmaceutical Industry digital vision

Tags: ,
October 24, 2013

IBM to help doctors fight heart disease with smarter use of data

How do you know if you’re at risk for heart failure?

The answers might be right there in a doctor’s records, said Shahram Ebadollahi, a director in the healthcare informatics group at IBM Research told CITEworld. They just need to dig through all their data and connect the dots.

IBM Research, Sutter Health, and Geisinger Health System have been granted $2 million for a joint research from the National Institutes of Health (NIH) to develop a new type of analytics and application methods that could help doctors detect heart failure years earlier than they do now.

IBM and its health care partners hope to develop methods that will catch signs of heart failure anywhere from six to 24 months ahead of time. With enough time, the patient might be able to fix it with lifestyle changes, or get on the proper medications.

See on www.citeworld.com

From Pharmaceutical Industry digital vision

Tags: ,
October 14, 2013

IBM to help doctors fight heart disease with smarter use of data

How do you know if you’re at risk for heart failure?

The answers might be right there in a doctor’s records, said Shahram Ebadollahi, a director in the healthcare informatics group at IBM Research told CITEworld. They just need to dig through all their data and connect the dots.

IBM Research, Sutter Health, and Geisinger Health System have been granted $2 million for a joint research from the National Institutes of Health (NIH) to develop a new type of analytics and application methods that could help doctors detect heart failure years earlier than they do now.

IBM and its health care partners hope to develop methods that will catch signs of heart failure anywhere from six to 24 months ahead of time. With enough time, the patient might be able to fix it with lifestyle changes, or get on the proper medications.

The project is dependent on doctors using electronic health records. If they still do everything on paper, it won’t do any good, said Ebadollahi. The system will examine health records to help detect heart failure earlier, identify best practices that help health systems nationwide integrate analytics into primary care, and take an expansive view of a patient’s health history.

See on www.citeworld.com

From Pharmaceutical Industry digital vision

Tags: ,
August 18, 2013

Why Healthcare Can’t Afford Not to Improve B2B Integration – Webcast – 2013/09/10 11:00:00 PDT

Watch this webinar to discover how IBM solutions can help your organization meet the challenges ahead, and see how advanced B2B integration strategies make it possible to process claims faster, reduce data breaches, improve customer service—and…

In today’s healthcare industry, seamless information sharing is a critical part of ensuring compliance with the Affordable Care Act as well as many other mandates and market demands. But how can you integrate data between platforms quickly, efficiently and affordably?

Watch this webinar to discover how IBM solutions can help your organization meet the challenges ahead, and see how advanced B2B integration strategies make it possible to process claims faster, reduce data breaches, improve customer service—and reduce costs.

You will learn:

How to deal with the complexity and expense of reliaby and securely moving data across the healthcare ecosystem while supporting HIPAA standards, health exchange requirements and moreAbout the problems companies are trying to solve, and how they’re improving connectivity across the broader healthcare spectrum Ways IBM solutions can help solve the most complex healthcare B2B integration challenges

See on webinar.informationweek.com

From Pharmaceutical Industry digital vision

Tags: ,